Depolarization of METHODS AND MATERIALS Cells were grown as monolayers under 5% CO2 in Eagle's minimal essential medium supplemented with 10% fetal bovine serum and 2 mM glutamine.
noncompetitive. These results indicate that dihydropyridines show a variety of effects on calcium channels, ranging from agonistic through partially agonistic to antagonistic. Moreover, the results also indicate that dihydropyridines and D-600 exert their effects on calcium channels at different sites.
The last few years have seen the development of a group of drugs that appear to block the flow of Ca2" through voltagesensitive calcium channels (VSCC) (1) (2) (3) (4) . For example, drugs such as verapamil, diltiazem, and the dihydropyridine nifedipine are now widely used in the treatment of angina, cardiac arrhythmias, and hypertension. Elucidating the molecular basis of the action of such agents is clearly a subject of great interest at present. Calcium channel blocking drugs fall into a variety of chemical types (1, 4) . It is quite possible that different drug classes block VSCC by different mechanisms (5) (6) (7) (8) (9) (10) (11) . Recently, a dihydropyridine (BAY K8644) has been reported that causes smooth muscle to contract and stimulates cardiac contractility (12) . It was suggested that this agent might act by opening VSCC rather than blocking them. We now demonstrate VSCC activation by this compound and show that this property is shared by another dihydropyridine, CGP 28392.
METHODS AND MATERIALS
Cells were grown as monolayers under 5% CO2 in Eagle's minimal essential medium supplemented with 10% fetal bovine serum and 2 mM glutamine.
Cells were subcultured onto 60-mm tissue culture plates and allowed to grow for 3 days. To induce cellular differentiation (13), growth media was supplemented with 10 AuM prostaglandin E1 and 50 AM 3-isobutyl-1-methylxanthene. In parallel experiments, other workers in our laboratory have shown that this treatment will increase intracellular cyclic AMP levels by 10-to 100-fold (unpublished observations). Cells were examined visually for morphological differentiation and were assayed for net 45Ca2+ uptake at various time points after treatment as indicated in the figure legends. Supplemented medium was replaced every 2 days or when required.
45Ca2+ Uptake Studies. Cells (passage [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] were subcultured onto 60-mm tissue culture plates and induced to differentiate as above. During the assay, tissue culture plates were supported in an open-air waterbath at 370C. Cells were incubated for 5 min at 37TC before the assay. Details of 45Ca2+ flux studies are given in the individual figure legends. The uptake of 45Ca2+ was measured for increasing periods of time in Hepes (20 mM) buffered Eagle's minimal essential medium containing 135.7 mM NaCl, 5 mM KCl, 0.44 mM KH2PO4, 0.34 mM Na2HPO4, 2.62 mM NaHCO3, 1.3 mM CaC12, 0.81 mM MgSO4, and 5.6 mM glucose. Buffer with 50 mM KCl was the same except that NaCl was 90.7 mM. 45Ca2+ was added to give a final concentration of 1 /LCi/ml (1 Ci = 37 GBq). At the indicated times, plates were aspirated, washed immediately, and inverted to allow to dry. Cells were solubilized with 5 ml of 0.2% sodium dodecyl sulfate and samples were removed for estimation of 45Ca uptake and protein content by fluorescence (14) .
Materials. 45Ca2+ (10-40 mCi/mg of Ca2+) was obtained from Amersham. Nitrendipine and BAY K8644 were from Miles Laboratories (New Haven, CT), D-600 from Knoll (Ludwigshafen, F.R.G.), diltiazem from Marion Laboratories (Kansas City, MO), and CGP 28392 from'CIBA-Geigy (Summit, NJ).
RESULTS AND DISCUSSION
We have shown that several clonal cell lines express VSCC that are similar to those found in smooth muscle in that they are blocked by low concentrations of dihydropyridines (13, 15) . This is the case, for example, with the neuroblastomaglioma cell line NG108-15. As can be seen in Fig. 1A , when these cells are subjected to depolarization by 50 mM K+ they show a rapid increase in the net uptake of 45Ca2+. Other studies have established that this influx is through VSCC (13, 15) . For example, it is not blocked by tetrodotoxin and is independent of the presence of external Na+. Moreover, the depolarization-induced influx is potently inhibited by dihydropyridines such as nitrendipine at nanomolar concentrations (nitrendipine IC50 = 6.5 nM). Other organic calcium channel blockers are also effective, as are inorganic channel blockers such as Cd2+ and Co2+.
In Fig. 1A , it can be seen that addition of BAY K8644
(structure in Fig. 2 In the presence of a maximally effective concentration of BAY K8644, the effect of 50 mM K+ is enhanced approximately 4-fold. Another dihydropyridine, CGP 28392 [4-(2-difluormethoxy)phenyl-1,4,7,7-tetrahydro-2-methyl-5-oxofuropyridine-3-carboxylic acid ethyl ester (Fig. 2) fect on 45Ca2" uptake into 3T3 fibroblasts under nondepolarizing (5 mM K+) or depolarizing (50 mM K+) conditions. As discussed above, both inorganic and organic VSCC blockers inhibit depolarization-induced 45Ca2+ uptake into NG108-15 cells. This is also the case for the stimulation produced by both BAY K8644 and CGP 28392. This can be seen in Fig. 4 . The effects of both drugs can be inhibited by nitrendipine, an "antagonist" dihydropyridine. Thus, nitrendipine blocks both the normal 50 mM K+-induced 45Ca2+ uptake and the extra increment resulting from the presence of either BAY K8644 or CGP 28392. Fig. 5 shows that the inhibitory effect of nitrendipine on BAY K8644-induced stimulation is competitive in nature. Thus, as might be expected, both types of dihydropyridine appear to interact with the channel at the same site. The effects of BAY K8644 and CGP 28392 are also blocked by the organic VSCC blockers D-600 (methoxyverapamil) and diltiazem and also by the inorganic channel blocker Cd2+ (Fig. 4) . Fig. 5 shows, however, that the blocking effects of D-600 are not of a simple competitive nature. This is in agreement with the suggestion of Schramm et al. (12) . Clearly, therefore, dihydropyridines and D-600 interact with VSCC at different sites, a fact that has been predicted from biochemical labeling studies of VSCC utilizing [3H]nitrendipine (5) (6) (7) (8) (9) (10) (11) .
It was observed (Fig. 3 ) that a maximal concentration of CGP 28392 produced less of an effect than BAY K8644. This suggests that CGP 28392 might act as a partial agonist. Indeed, CGP 28392 can inhibit the effects of BAY K8644.
When 300 nM BAY K8644 and 1 ;tM CGP 28392 are added together, the resulting enhancement of 50 mM K+-stimulated 45Ca2+ uptake is 79% of that obtained with 300 nM BAY K8644 only. Our results show that dihydropyridines can produce a range of effects on VSCC. Thus, compounds such as nitrendipine act as pure "antagonists," whereas those such as BAY K8644 act as "agonists." Other substances such as CGP 28392 have an intermediate action and may be considered partial agonists. In this respect, it is interesting to note at low concentrations nifedipine has been reported to have agonist effects (16) .
It should be noted that in biochemical labeling studies, the total number of VSCC observed (Bmax) appears to be dependent on the particular radioactive dihydropyridine utilized (17) . It is possible that this is a result of differences in the "purity" of antagonist activity associated with different dihydropyridine structures.
